Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Takeda divests TachoSil to Ethicon

Executive Summary

Takeda Pharmaceutical Co. Ltd. entered into an agreement to divest its TachoSil fibrin sealant patch and related assets to Johnson & Johnson’s Ethicon Inc. for $400mm in cash.
Deal Industry
  • Medical Devices
    • Biomaterials
    • Surgical Equipment & Devices
      • Surgical Sealants
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing-Licensing
    • Product Purchase

Related Companies

Advertisement
UsernamePublicRestriction

Register